Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-48 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-24 |
filingDate |
2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34345ae7a7dd96df40ef9cfd7df423c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5753607cc60f353fa502d000c0627f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab4f17ae54dbdcfb58cf90d1df2a787 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be36aeefff95b9630d0a98f1a676c41 |
publicationDate |
2022-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3765005-A4 |
titleOfInvention |
INHIBITORS OF INTEGRIN ALPHA 2 BETA 1 AND METHOD OF USE |
priorityDate |
2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |